Articles by Gil Y. Melmed, MD

1 2 3 4 5

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD

Yoon, Soon Man; Haritunians, Talin; Chhina, Sultan; More

Inflammatory Bowel Diseases. 23(8):1382-1393, August 2017.

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease

Nguyen, Geoffrey C.; Boland, Karen; Afif, Waqqas; More

Inflammatory Bowel Diseases. 23(6):858-865, June 2017.

Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD)

IsHak, Waguih W.; Pan, Dana; Steiner, Alexander J.; More

Inflammatory Bowel Diseases. 23(5):798-803, May 2017.

Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers

Tinsley, Andrew; Ehrlich, Orna G.; Hwang, Caroline; More

Inflammatory Bowel Diseases. 22(10):2474-2481, October 2016.

Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch–anal Anastomosis

Koh, Sharon Z.; Zaghiyan, Karen N.; Li, Quanlin; More

Inflammatory Bowel Diseases. 22(6):1397-1402, June 2016.

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel

Devlin, Shane M.; Melmed, Gil Y.; Irving, Peter M.; More

Inflammatory Bowel Diseases. 22(6):1418-1424, June 2016.

Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway

Kaur, Manreet; Panikkath, Deepa; Yan, Xiaofei; More

Inflammatory Bowel Diseases. 22(4):862-869, April 2016.

Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease

Dezfoli, Seper; Horton, Henry A.; Thepyasuwan, Nattapaun; More

Inflammatory Bowel Diseases. 21(8):1754-1760, August 2015.

Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study

Melmed, Gil Y.; Pandak, William M.; Casey, Kevin; More

Inflammatory Bowel Diseases. 21(8):1809-1816, August 2015.

Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease

Singh, Namita; Rosenthal, Casey J.; Melmed, Gil Y.; More

Inflammatory Bowel Diseases. 20(10):1708-1713, October 2014.

Clinical, Serologic, and Genetic Factors Associated with Pyoderma Gangrenosum and Erythema Nodosum in Inflammatory Bowel Disease Patients

Weizman, Adam; Huang, Brian; Berel, Dror; More

Inflammatory Bowel Diseases. 20(3):525-533, March 2014.

Video Capsule Endoscopy Impacts Decision Making in Pediatric IBD: A Single Tertiary Care Center Experience

Min, Steve B.; Le-Carlson, Minou; Singh, Namita; More

Inflammatory Bowel Diseases. 19(10):2139-2145, September 2013.

Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study

Mayer, Lloyd; Pandak, William M.; Melmed, Gil Y.; More

Inflammatory Bowel Diseases. 19(4):754-760, March-April 2013.

Quality Indicators for Inflammatory Bowel Disease: Development of Process and Outcome Measures

Melmed, Gil Y.; Siegel, Corey Allan; Spiegel, Brennan M.; More

Inflammatory Bowel Diseases. 19(3):662-668, March 2013.

Genetic predictors of medically refractory ulcerative colitis

Haritunians, Talin; Taylor, Kent D.; Targan, Stephan R.; More

Inflammatory Bowel Diseases. 16(11):1830-1840, November 2010.

1 2 3 4 5